NALFON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nalfon, and when can generic versions of Nalfon launch?
Nalfon is a drug marketed by Key Therap and Dista and is included in two NDAs.
The generic ingredient in NALFON is fenoprofen calcium. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nalfon
A generic version of NALFON was approved as fenoprofen calcium by RISING on July 18th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NALFON?
- What are the global sales for NALFON?
- What is Average Wholesale Price for NALFON?
Summary for NALFON
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 97 |
Patent Applications: | 4,297 |
Drug Prices: | Drug price information for NALFON |
What excipients (inactive ingredients) are in NALFON? | NALFON excipients list |
DailyMed Link: | NALFON at DailyMed |
Pharmacology for NALFON
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for NALFON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Key Therap | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dista | NALFON | fenoprofen calcium | TABLET;ORAL | 017710-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Key Therap | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Key Therap | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-004 | Jul 21, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NALFON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Key Therap | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Dista | NALFON | fenoprofen calcium | TABLET;ORAL | 017710-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Key Therap | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NALFON
See the table below for patents covering NALFON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 780846 | ⤷ Sign Up | |
Denmark | 240677 | ⤷ Sign Up | |
Netherlands | 155820 | ⤷ Sign Up | |
Cyprus | 743 | Substituted phenylalkanoic acids and derivatives thereof | ⤷ Sign Up |
Finland | 54099 | ⤷ Sign Up | |
Sweden | 398639 | FORFARANDE FOR FRAMSTELLNING AV SUBSTITUERADE FENYLALKANSYRAFORENINGAR | ⤷ Sign Up |
Luxembourg | 59302 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |